Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasgenetics-dysmorphology-and-metabolism

Paeds Vivas · genetics-dysmorphology-and-metabolism

Ethical issues in genomic diagnosis and cascade testing

Viva on the ethical classification of paediatric genetic tests and the management of predictive testing, secondary findings, and cascade testing.

structured-oral
On this page & tools

Target exams

racp_advancedracp_dcemrcpch_clinical

Target exams

racp_advancedracp_dcemrcpch_clinical
Prompt
A clinical geneticist asks you to discuss the ethics of genetic testing in children across four scenarios. **Discuss:** (1) how you classify a paediatric genetic test by its ethical demand (diagnostic, predictive, carrier, susceptibility) and the single question that resolves most dilemmas; (2) the position on predictive testing for an adult-onset condition with no childhood benefit versus a childhood-actionable condition such as MEN2, and the principle that governs the difference; (3) the ACMG secondary-findings list as an opt-in framework, the evolution of the policy, and what happens when an actionable variant is found without prior consent; (4) the cascade-testing pathway, including the proband's confidentiality, the mechanism for contacting relatives, and the right not to know.